Melbourne, Australia, 22 October 2013: Neuren Pharmaceuticals (ASX: NEU) announced today that it has completed a placement of new shares to professional and sophisticated investors at 11.5 cents per share, providing additional capital of $21.5 million. The placement was heavily over-subscribed, an indication of the strong support from international and domestic institutional investors. Neuren also intends to offer a Share Purchase Plan at 11.5 cents per share, capped at $3 million, to shareholders registered at 7pm AEST on 18 October 2013.
announcement
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |